AAAAAA

   
Results: 1-7 |
Results: 7
PRECLINICAL EVALUATION OF 5-IODO-2-PYRIMIDINONE-2'-DEOXYRIBOSE AS A PRODRUG FOR 5-IODO-2'-DEOXYURIDINE-MEDIATED RADIOSENSITIZATION IN MOUSEAND HUMAN TISSUES
Authors: KINSELLA TJ KUNUGI KA VIELHUBER KA POTTER DM FITZSIMMONS ME COLLINS JM
Citation: Tj. Kinsella et al., PRECLINICAL EVALUATION OF 5-IODO-2-PYRIMIDINONE-2'-DEOXYRIBOSE AS A PRODRUG FOR 5-IODO-2'-DEOXYURIDINE-MEDIATED RADIOSENSITIZATION IN MOUSEAND HUMAN TISSUES, Clinical cancer research, 4(1), 1998, pp. 99-109
PRECLINICAL EVALUATION OF 5-IODO-2-PYRIMIDINONE-2'-DEOXYRIBOSE AS A PRODRUG FOR 5-IODO-2'-DEOXYURIDINE-MEDIATED RADIOSENSITIZATION IN MOUSEAND HUMAN TISSUES
Authors: KINSELLA TJ KUNUGI KA VIELHUBER KA POTTER DM FITZSIMMONS ME COLLINS JM
Citation: Tj. Kinsella et al., PRECLINICAL EVALUATION OF 5-IODO-2-PYRIMIDINONE-2'-DEOXYRIBOSE AS A PRODRUG FOR 5-IODO-2'-DEOXYURIDINE-MEDIATED RADIOSENSITIZATION IN MOUSEAND HUMAN TISSUES, Clinical cancer research, 4(1), 1998, pp. 99-109
SELECTIVE BIOTRANSFORMATION OF THE HUMAN-IMMUNODEFICIENCY-VIRUS PROTEASE INHIBITOR SAQUINAVIR BY HUMAN SMALL-INTESTINAL CYTOCHROME P4503A4 - POTENTIAL CONTRIBUTION TO HIGH FIRST-PASS METABOLISM
Authors: FITZSIMMONS ME COLLINS JM
Citation: Me. Fitzsimmons et Jm. Collins, SELECTIVE BIOTRANSFORMATION OF THE HUMAN-IMMUNODEFICIENCY-VIRUS PROTEASE INHIBITOR SAQUINAVIR BY HUMAN SMALL-INTESTINAL CYTOCHROME P4503A4 - POTENTIAL CONTRIBUTION TO HIGH FIRST-PASS METABOLISM, Drug metabolism and disposition, 25(2), 1997, pp. 256-266
MECHANISMS OF ENHANCED ORAL AVAILABILITY OF CYP3A4 SUBSTRATES BY GRAPEFRUIT CONSTITUENTS - DECREASED ENTEROCYTE CYP3A4 CONCENTRATION AND MECHANISM-BASED INACTIVATION BY FURANOCOUMARINS
Authors: SCHMIEDLINREN P EDWARDS DJ FITZSIMMONS ME HE K LOWN KS WOSTER PM RAHMAN A THUMMEL KE FISHER JM HOLLENBERG PF WATKINS PB
Citation: P. Schmiedlinren et al., MECHANISMS OF ENHANCED ORAL AVAILABILITY OF CYP3A4 SUBSTRATES BY GRAPEFRUIT CONSTITUENTS - DECREASED ENTEROCYTE CYP3A4 CONCENTRATION AND MECHANISM-BASED INACTIVATION BY FURANOCOUMARINS, Drug metabolism and disposition, 25(11), 1997, pp. 1228-1233
MEDIUM-CHAIN ACYL-COA DEHYDROGENASE-DEPENDENT AND ENOYL-COA HYDRATASE-DEPENDENT BIOACTIVATION OF 5,6-DICHLORO-4-THIA-5-HEXENOYL-COA
Authors: FITZSIMMONS ME THORPE C ANDERS MW
Citation: Me. Fitzsimmons et al., MEDIUM-CHAIN ACYL-COA DEHYDROGENASE-DEPENDENT AND ENOYL-COA HYDRATASE-DEPENDENT BIOACTIVATION OF 5,6-DICHLORO-4-THIA-5-HEXENOYL-COA, Biochemistry, 34(13), 1995, pp. 4276-4286
NEPHROTOXICITY AND HEPATOTOXICITY OF 5,6-DICHLORO-4-THIA-5-HEXENOIC ACID - EVIDENCE FOR FATTY-ACID BETA-OXIDATION-DEPENDENT BIOACTIVATION
Authors: FITZSIMMONS ME BAGGS RB ANDERS MW
Citation: Me. Fitzsimmons et al., NEPHROTOXICITY AND HEPATOTOXICITY OF 5,6-DICHLORO-4-THIA-5-HEXENOIC ACID - EVIDENCE FOR FATTY-ACID BETA-OXIDATION-DEPENDENT BIOACTIVATION, The Journal of pharmacology and experimental therapeutics, 271(1), 1994, pp. 515-523
FATTY-ACID BETA-OXIDATION-DEPENDENT BIOACTIVATION OF HALOGENATED THIAALKANOIC ACIDS IN ISOLATED RAT HEPATOCYTES
Authors: FITZSIMMONS ME ANDERS MW
Citation: Me. Fitzsimmons et Mw. Anders, FATTY-ACID BETA-OXIDATION-DEPENDENT BIOACTIVATION OF HALOGENATED THIAALKANOIC ACIDS IN ISOLATED RAT HEPATOCYTES, Chemical research in toxicology, 6(5), 1993, pp. 662-668
Risultati: 1-7 |